![](/img/cover-not-exists.png)
49 PHASE II STUDY ERLOTINIB/RT AND CHT/RT FOLLOWED BY CONSOLIDATION OF CHT FOR PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): ANALYSIS OF PATIENT SPECIMENS FOR BIOMARKERS
R. Komaki, I.I. Wistuba, R.E. Meyn, J.J. Lee, X. Wei, P.K. Allen, X.M. Tang, M. O'Reilly, J. Welsh, W.K. HongVolume:
102
Year:
2012
Language:
english
DOI:
10.1016/s0167-8140(12)70033-6
File:
PDF, 67 KB
english, 2012